首页|Efficacy of plasma exchange in adjuvant treatment of chronic and acute liver failure
Efficacy of plasma exchange in adjuvant treatment of chronic and acute liver failure
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
万方数据
维普
Objective: To study and evaluate the clini1cal effect of plasma exchange in the adjuvant treatment of chronic and acute liver failure. Methods:Totally 60 patients with chronic and acute liver failure in our department were divided into two groups. The control group received comprehensive treatment and the plasma exchange group received plasma exchange. The changes of total bilirubin(TBIL) ,PT percentage activity(PTA), alanine aminotransferase(ALT), aspartate aminotransferase(AST), albumin(ALB), interleukin-6(IL-6), procalcitonin(PCT) and C-reactive protein (CRP) were measured after treatment, and were assessed in terms of the degree of relief of clinical symptoms. Results: TBIL, ALB, Alt, AST, IL-6, PCT and CRP in the two groups decreased and PTA increased compared with those before treatment, but the curative effect of the treatment group was better than that of the control group (P<0.05).The total effective rate of the treatment group was 80.0％, which was higher than 46.6％ of the treatment group (P<0.05). Conclusion: Plasma exchange can help to improve the liver function, remove a large number of inflammatory factors, promote the recovery of liver function and improve the prognosis of patients with chronic and acute liver failure.
Artificial liverChronic and acute liver failureImpact assessment
LI Chu?yi、WANG Jun-ke、LI Bin、WEN Xue、WEI Xiao-jing、YU Xiao-hui
展开 >
Department of Gastroenterology,940 Hospital of Joint Service of PLA,Gansu Lanzhou 730050,China
Ningxia Medical University,Ningxia Yinchuan 750004,China
NETL
NSTL
万方数据
维普
